Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Non-Current Deferred Tax Liability (2024 - 2025)

Historic Non-Current Deferred Tax Liability for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to $364.0 million.

  • Genmab A's Non-Current Deferred Tax Liability rose 1030.3% to $364.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $364.0 million, marking a year-over-year increase of 1030.3%. This contributed to the annual value of $364.0 million for FY2025, which is 1030.3% up from last year.
  • Latest data reveals that Genmab A reported Non-Current Deferred Tax Liability of $364.0 million as of Q4 2025, which was up 1030.3% from $330.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Non-Current Deferred Tax Liability registered a high of $364.0 million during Q4 2025, and its lowest value of $330.0 million during Q4 2024.